ACOG (Alpha Cognition) Return-on-Tangible-Asset: -34.97% (As of Mar. 2026)


ACOG Alpha Cognition Inc ACOG
32 GF Score
Price $7.89
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition Return-on-Tangible-Asset?

Alpha Cognition ACOG +1.28% 32 Return-on-Tangible-Asset is -34.97% as of Mar. 2026. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,417 Biotechnology companies, Alpha Cognition ranks worse than 55.54% on this metric.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Alpha Cognition's annualized Net Income for the quarter that ended in Mar. 2026 was $-25.91 Mil. Alpha Cognition's average total tangible assets for the quarter that ended in Mar. 2026 was $74.10 Mil. Therefore, Alpha Cognition's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -34.97%.

The historical rank and industry rank for Alpha Cognition's Return-on-Tangible-Asset or its related term are showing as below:

ACOG' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -646.65   Med: -120.96   Max: -31.88
Current: -43.8

During the past 6 years, Alpha Cognition's highest Return-on-Tangible-Asset was -31.88%. The lowest was -646.65%. And the median was -120.96%.

ACOG's Return-on-Tangible-Asset is ranked worse than
55.54% of 1417 companies
in the Biotechnology industry
Industry Median: -35.77 vs ACOG: -43.80

Alpha Cognition  (NAS:ACOG) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Alpha Cognition Return-on-Tangible-Asset Related Terms


Alpha Cognition Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Alpha Cognition's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Cognition Return-on-Tangible-Asset Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Asset
Get a 7-Day Free Trial -196.53 -166.87 -646.65 -56.62 -31.88

Alpha Cognition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.01 -90.30 -11.63 -43.79 -34.97

ACOG vs HURA, MENS, ENLV: Return-on-Tangible-Asset Comparison

For the Biotechnology subindustry, Alpha Cognition's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Cognition Return-on-Tangible-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Return-on-Tangible-Asset falls into.


ACOG
32GF Score
Alpha Cognition Inc ACOG
Return-on-Tangible-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition Return-on-Tangible-Asset Calculation

Alpha Cognition's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-20.67/( (50.324+79.339)/ 2 )
=-20.67/64.8315
=-31.88 %

Alpha Cognition's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-25.912/( (79.339+68.862)/ 2 )
=-25.912/74.1005
=-34.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data.

What does a Return-on-Tangible-Asset of -34.97% mean?
Alpha Cognition (ACOG) has a Return-on-Tangible-Asset of -34.97% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alpha Cognition and its competitors. According to the industry distribution chart, Alpha Cognition ranks #787 out of 1417 companies in the Biotechnology industry, placing it in the top 55.5%.
Is Alpha Cognition's Return-on-Tangible-Asset too high?
Alpha Cognition's current Return-on-Tangible-Asset is -34.97%. Based on the distribution chart, Alpha Cognition ranks #787 out of 1417 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Return-on-Tangible-Asset compare to HURA and MENS?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #787 out of 1417 companies for Return-on-Tangible-Asset. This places Alpha Cognition in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Biotechnology company?
A good Return-on-Tangible-Asset depends on the Biotechnology industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alpha Cognition and its competitors. Alpha Cognition's current Return-on-Tangible-Asset is -34.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Return-on-Tangible-Asset of -34.97%. The current Return-on-Tangible-Asset is -34.97%. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Return-on-Tangible-Asset is -34.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score

Get the complete analysis for ACOG

Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.89
Price